Primary squamous cell carcinoma of the breast: report of two cases with HER2 overexpression

References

• Gupta C, Malani AK, Weigand RT, Rangineni G. Pure primary squamous cell carcinoma of the breast: a rare presentation and clinicopathologic comparison with usual ductal carcinoma of the breast. Pathol Res Pract. 2006;202:465–469. doi:10.1016/j.prp.2006.01.006.
   PubMed Web of Science ®Google Scholar
• Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ. WHO classification of tumours of the breast. 4th ed. Lyon: IARC Press. 2012. ISBN 978-92-832-2433-4.
   Google Scholar
• Schroeder MC, Rastogi P, Geyer CE Jr, Miller LD, Thomas A. Early and locally advanced metaplastic breast cancer: presentation and survival by receptor status in surveillance, epidemiol ogy, and end results (SEER) 2010–2014. Oncologist. 2018;23:481–488. doi:10.1634/theoncologist.2017-0398.
   PubMed Web of Science ®Google Scholar
• Honda M, Saji S, Horiguchi SI, Suzuki E, Aruga T, Horiguchi K, Kitagawa D, Sekine S, Funata N, Toi M, et al. Clinicopathological analysis of ten patients with metaplastic squamous cell carcinoma of the breast. Surg Today. 2011;41:328–332. doi:10.1007/s00595-009-4276-2.
   PubMed Web of Science ®Google Scholar
• Shui RH, Li AQ, Yang F, Zhou XY, Yu BH, Xu XL, Yang WT. Primary squamous cell carcinoma of the breast with unusual basal-HER2 phenotype. Int J Clin Exp Pathol. 2014;7:5203–5209.
   PubMed Web of Science ®Google Scholar
• Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/Col- lege of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31:3997–4013. doi:10.1200/JCO.2013.50.9984.
   PubMed Web of Science ®Google Scholar
• Behranwala KA, Nasiri N, Abdullah N, Trott PA, Gui GP. Squamous cell carcinoma of the breast: clinico-pathologic implications and outcome. Eur J Surg Oncol. 2003;29:386–389. doi:10.1053/ejso.2002.1422.
   PubMedGoogle Scholar
• Motoyama T, Watanabe H. Extremely well differentiated squamous cell carcinoma of the breast. Report of a case with a comparative study of an epidermal cyst. Acta Cytol. 1996;40:729–733. doi:10.1159/000333947.
   PubMed Web of Science ®Google Scholar
• Hasleton PS, Misch KA, Vasudev KS, George D. Squamous carcinoma of the breast. J Clin Pathol. 1978;31:116–124. doi:10.1136/jcp.31.2.116.
   PubMed Web of Science ®Google Scholar
• Gupta RK, Dowle CS. Cytodiagnosis of pure primary squamous-cell carcinoma of the breast by fine-needle aspiration cytology. Diagn Cytopathol. 1997;3:197–199. doi:10.1002/(SICI)1097-0339(199709)17:3<197::AID-DC5>3.0.CO;2-C.
   Google Scholar
• Karamouzis MV, Fida A, Apostolikas N, Rigatos G. A case of Her-2 positive squamous cell breast carcinoma: an unusual presentation of an unusual clinical entity. EJSO. 2006;32:1250–1251. doi:10.1016/j.ejso.2006.05.008.
   PubMed Web of Science ®Google Scholar
• Pribish AM, Saglam O, Weinfurtner RJ. Estrogen receptor-positive primary squamous cell carcinoma of the breast. Radiol Case Rep. 2017;12:211–214. doi:10.1016/j.radcr.2017.01.008.
   PubMedGoogle Scholar
• Cardoso F, Leal C, Meira A, Azevedo R, Mauricio MJ, Leal Da Silva JM, Lopes C, Pinto FE. Squamous cell carcinoma of the breast. Breast. 2000;9:315–319. doi:10.1054/brst.1999.0145.
   PubMed Web of Science ®Google Scholar
• Gatti V, Bongiorno-Borbone L, Fierro C, Annicchiarico-Petruzzelli M, Melino G, Peschiaroli A. p63 at the crossroads between stemness and metastasis in breast cancer. Int J Mol Sci. 2019;20(11):2683. doi:10.3390/ijms20112683.
   Web of Science ®Google Scholar
• Bhatt L, Fernando I. Primary squamous cell carcinoma of the breast: achieving long-term control with cisplatin-based chemotherapy. Clin Breast Cancer. 2009;9:187–188. doi:10.3816/CBC.2009.n.031.
   PubMed Web of Science ®Google Scholar
• Hennessy BT, Krishnamurthy S, Giordano S, Buchholz TA, Kau SW, Duan Z, Valero V, Hortobagyi GN. Squamous cell carcinoma of the breast. J Clin Oncol. 2005;23:7827–7835. doi:10.1200/JCO.2004.00.9589.
   PubMedGoogle Scholar
• Menes T, Schachter J, Morgenstern S, Fenig E, Lurie H, Gutman H. Primary squamous cell carcinoma (SqCC) of the breast. Am J Clin Oncol. 2003;26:571–573. doi:10.1097/01.coc.0000045809.85995.3B.
   PubMed Web of Science ®Google Scholar
• He XX, Ji JL, Dong RR, Liu H, Dai XL, Wang CJ, Esteva FJ, Jim YSC. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis. Breast Cancer Res Treat. 2019;173:329–341. doi:10.1007/s10549-018-5005-6.
   PubMed Web of Science ®Google Scholar
• Del Campo JM, Hitt R, Sebastian P, Carracedo C, Lokanatha D, Bourhis J, Temam S, Cupissol D, De Raucourt D, Maroudias N, et al. Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck. Br J Cancer. 2011;105:618–627. doi:10.1038/bjc.2011.237.
   PubMed Web of Science ®Google Scholar
• Agus DB, Akita RW, Fox WD, Lewis GD, Higgins B, Pisacane PI, Lofgren JA, Tindell C, Evans DP, Maiese K, et al. Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth. Cancer Cell. 2002;2:127–137. doi:10.1016/S1535-6108(02)00097-1.
   PubMed Web of Science ®Google Scholar
• Capelan M, Pugliano L, De Azambuja E, Bozovic I, Saini KS, Sotiriou C, Loi S, Piccart-Gebhart MJ. Pertuzumab: new hope for patients with HER2-positive breast cancer. Ann Oncol. 2013;24:273–282. doi:10.1093/annonc/mds328.
   PubMed Web of Science ®Google Scholar
• Grabowski J, Saltzstein SL, Sadler G, Blair S. Squamous cell carcinoma of the breast: a review of 177 cases. Am Surg. 2009;75:914–917. doi:10.1177/000313480907501010.
   PubMed Web of Science ®Google Scholar
• Nayak A, Wu Y, Gilcrease MZ. Primary squamous cell carcinoma of the breast: predictors of locoregional recurrence and overall survival. Am J Surg Pathol. 2013;37:867–873. doi:10.1097/PAS.0b013e3182877569.
   PubMed Web of Science ®Google Scholar